key: cord-0016028-9snvzd2f authors: Duong, Kim Hoang Yen; Goldschmidt Gőz, Viktória; Pintér, István; Perczel, András title: Synthesis of chimera oligopeptide including furanoid β-sugar amino acid derivatives with free OHs: mild but successful removal of the 1,2-O-isopropylidene from the building block date: 2021-02-09 journal: Amino Acids DOI: 10.1007/s00726-020-02923-3 sha: 84569ce4bdd5abcdb52cd28eca9460f984f60433 doc_id: 16028 cord_uid: 9snvzd2f Complementary to hydrophobic five membered ring β-amino acids (e.g. ACPC), β-sugar amino acids (β-SAAs) have found increasing application as hydrophilic building blocks of foldamers and α/β chimeric peptides. Fmoc-protected β-SAAs [e.g. Fmoc-RibAFU(ip)-OH] are indeed useful Lego elements, ready to use for SPPS. The removal of 1,2-OH isopropylidene protecting group increasing the hydrophilicity of such SAA is presented here. We first used N(3)-RibAFU(ip)-OH model compound to optimize mild deprotection conditions. The formation of the 1,2-OH free product N(3)-RibAFU-OH and its methyl glycoside methyl ester, N(3)-RibAFU(Me)-OMe were monitored by RP-HPLC and found that either 50% TFA or 8 eqv. Amberlite IR-120 H(+) resin in MeOH are optimal reagents for the effective deprotection. These conditions were then successfully applied for the synthesis of chimeric oligopeptide: -GG-X-GG- [X=RibAFU(ip)]. We found the established conditions to be effective and—at the same time—sufficiently mild to remove 1,2-O-isopropylidene protection and thus, it is proposed to be used in the synthesis of oligo- and polypeptides of complex sequence combination. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00726-020-02923-3) contains supplementary material, which is available to authorized users. Oligopeptides containing β-amino acids (β-peptides) have favorable backbone folding properties as foldamers (Gellman 1998; Hill et al. 2001; Seebach et al. 1996) . Numerous oligomers made from diastereomers of 2-aminocyclopentanecarboxylic acid (ACPC) (Abraham et al. 2010; Appella et al. 1999a; Martinek et al. 2002) and 2-aminocyclohexanecarboxylic acid (ACHC) (Appella et al. 1996; Appella et al. 1999b; Hetényi et al. 2005) are regarded as benchmark nanosystems incorporating cyclic β-amino acids. However, the hydrophobic character enhanced by ACPC and ACHC residues is a serious drawback during their potential physiological application. In fact, their homooligomers are insoluble in water (Hetényi et al. 2009 ). This can be amended by introducing sugar amino acids (SAAs) (Risseeuw et al. 2009 (Risseeuw et al. , 2013 which are more hydrophilic by nature. It has been shown particularly, both for five-and six-membered cyclic SAAs (H-SAA-OHs) to behave as appropriate building blocks (Nagy et al. 2017; Csordás et al. 2016; Goldschmidt Gőz et al. 2018; Suhara et al. 2006; Chandrasekhar et al. 2004; Gruner et al. 2002a, b; Pandey et al. 2011) . Furanoid β-SAAs, e.g., 3-amino-3-deoxy-d-furanuronic acids (AFUs), primarily, d-xylo (1, 2) and d-ribo (3, 4) epimeric pairs (Nagy et al. 2017 ) are hydrophilic analogs of cis-and trans-ACPC (Fig. 1) . The cost-effective synthesis of oligopeptides incorporating both furanoid and pyranoid β-SAAs were recently done in our group (Csordás et al. 2016; Nagy et al. 2019) . The stable protection of the hydroxyl groups of β-SAA is essential during the synthesis of oligo-and polypeptides. Afterwards, the removal of their protecting groups is of a special interest to enhance the hydrophilicity of the parent chimera peptides (Suhara et al. 2006; Schweizer 2002; Gruner et al. 2002a, b; Chakraborty et al. 2002) . In principle, the hydrophilic moieties ensure the better compatibility with the living organism of aqueous media. In addition, the introduction of more hydrophilic residues makes these types of β-SAA building blocks tunable and more versatile and thus, enhanced biocompatibility could be achieved, otherwise crucial for drug delivery and biomedical applications. Both the N 3 -RibAFU(ip)-OH (7) and Fmoc-RibAFU(ip)-OH (8) β-SAA have their 1,2-O-isopropylidene protecting groups originating from 1,2;5,6-di-O-isopropylidene-d-glucofuranose (5) (Scheme 1) (Nagy et al. 2017) . Note that, the original 5,6-O-isopropylidene group was removed in one of the intermediary steps. The selective deprotection of 5,6-O-isopropylidene acetals of d-Glc is described using protic acids: e.g., H 2 SO 4 (Rbaa et al. 2020; Miljkovic 2009; Sukumar et al. 1986 ), HClO 4 on silica gel (Agarwal and Vankar 2005) , polyphosphoric acid on silica gel (Nikam and Gore 2020) or AcOH Pikas et al. 2020; Ferreira et al. 2020; Ravn et al. 2019; Gruner et al. 2002a, b; Yadav, Chander and Reddy 1992) . The application of some Lewis acids was also reported, such as FeCl 3 ·6H 2 O/SiO 2 (Kim et al. 1986 ), CuCl 2 ·2H 2 O (Iwata and Ohrui 1981) , Zn(NO 3 ) 2 ·6H 2 O (Vijayasaradhi, Singh and Aidhen 2000) , Yb(OTf) 3 ·H 2 O (Yadav et al. 2001 ) just as BiCl 3 (Swamy and Venkateswarlu 2002) . Alternative methods for the selective removal of the isopropylidene protection under relatively mild conditions were studied more recently as aqueous tert-butyl hydroperoxide (Maddani and Prabhu 2011) , CBr 4 -photoirradiation (Chen et al. 2004 ) and acid zeolites (Rauter et al. 2010) . The removal of 2,3-O-isopropylidene acetals is also presented in acidic conditions of TFA (Bornaghi et al. 2004; Ganapati and Arvind 2020; Ferreira et al. 2020; Gelin et al. 2020; Pogula et al. 2020; Ahmed-Belkacem et al. 2020) , AcOH (Decultot et al. 2020) , HCl (Ko et al. 2017) or BCl 3 (Yamamoto et al. 2019; Yoo et al. 2018) . For deprotection of 1,2-O-isopropylidene moieties, fewer approaches were mentioned, including H 2 SO 4 (Masamune et al. 2001; Yanaisaka et al. 1970) , HCl (Sorensen et al. 2001; Yanaisaka et al. 1970) , TsOH (Yuan et al. 2020; Sukumar et al. 1986; Rosenthal and Cliff 1980) , aqueous TFA (Piccini et al. 2020; Fernandez-Bolanos and Lopez 2007) or cationic exchange resins (e.g. Dowex-50 H + ) (Weber et al. 1986; Fleet and Smith 1985) . The deprotection conditions for various di-O-isopropylidene of sugar scaffolds are summarized in Table 1 . Although several papers described various conditions for the deprotection of isopropylidene acetals, no case of such 1,2-O-isopropylidene removal from SAAs oligopeptides is known. Only 2,3-O-isopropylidene removal was reported, when cyclic dimer of protected 5-aminomethyl-3,4-dihydroxy-tetrahydrofuran-2-yl-acetic acid (H-SAA-OH) without 2,3-O-isopropylidene acetal was formed in aqueous TFA (Bornaghi et al. 2004) . In a patent of antibody-drug conjugates, a linker as MC-SAA-Phe-Cit-APEA containing 5-azidomethyl-3,4-dihydroxy-tetrahydrofuran-2-yl-acetic acid (N 3 -SAA-OH) was synthesized and the 2,3-O-isopropylidene protection was removed with aqueous HCl, following the peptide synthesis (Ko et al. 2017) . Linkers having high hydrophilic SAAs were designed to reduce significantly or even avoid the use of organic solvents during the conjugation process. This can enhance high conjugation efficiency and the stability of conjugate products, which is important in drug development. Therefore, it seems essential to develop applicable approaches for peptides having 1,2-O-isopropylidene protected SAA building blocks. The main goals we set out to: (1) free the furanoid 1,2-OHs to increase the hydrophilicity of the molecule and (2) form methyl glycoside to prevent furanoid ring opening. Consequently, we synthesized our model oligopeptide Ac-GG-X-GG-R (Nagy et al. 2019) this time with X=RibAFU(ip) and R=OH or NH 2 and the removal conditions of the 1,2-O-isopropylidene protecting group were successfully probed. Realizing the two main goals, we took into account the essential criteria in both cases: only the planned reactions might happen and unwished transformations in the polypeptide chain (chain scission, rearrangement, elimination, etc.) cannot occur. To work out the conditions suitable for removal of 1,2-O-isopropylidene protection, the easily accessible intermediate N 3 -RibAFU(ip)-OH (7) (Scheme 1) was selected and probed. In addition, N 3 -RibAFU(ip)-NHMe (11) (Nagy et al. 2017) , the amide derivative of 7, was also used as proper model to provide the possibility of the comparison with the related oligopeptides. An efficient multigram synthesis of the sugar amino acid Fmoc-RibAFU(ip)-OH (8) was completed previously from d-Glc (Nagy et al. 2017) . The deprotection of the 5,6-O-isopropylidene moiety was achieved with diluted acetic acid (Scheme 1, step d). Then, N 3 -RibAFU(ip)-OH (7) was obtained from 6 and in the final steps Fmoc-RibAFU(ip)-OH (8) product was achieved. We have shown that Fmoc-RibAFU(ip)-OH (8) is a suitable monomer for solid-phase peptide synthesis (SPPS), as both the 1,2-OHs and the amino function are protected (Nagy et al. 2019) . The deprotection was carried out under strong acidic conditions (Scheme 2) and the reactions were followed by RP-HPLC. Chromatograms were well resolved and clearly showed the steadily decrease in concentration of the starting 7 (retention time 11.9 min). In Route A: Compound 7 was dissolved in the mixture of TFA in DCM of 50%, 70% and 90% concentrations in parallels together with a small amount of H 2 O (2.5%) and TIS (2.5%) as scavengers. All reactions were carried out at room temperature. Analysis of RP-HPLC diagrams resulted in evaluable data of the reaction with varied concentration of TFA. Since component 9 has hydrophilic character during the deprotection reactions, instead of a conventional C-18 column, Hydro-RP LC column was used for RP-HPLC system. The hydrolysis of 7 (retention time 21.6 min) was almost completed and no intermediate was detected . The new signal at 4.3 min was indicated and the reaction mixture was processed to give white oil, however, attempts to isolate a pure product failed. Due to the free OH-1 in 9 such mixture of the anomers could be expected. This fact was indicated by ESI-MS exhibiting a peak at m/z 188.03029 (SFig. 7) of the unprotected carboxylic acid (9). Further studies with HILIC LC-MS (Hydrophilic Interaction Chromatography) corroborated the presence of 9 in the mixture. In these chromatograms, the signal at 2.13 min was assigned to the starting Scheme 1 The synthesis of the furanoid β-SAA, Fmoc-RibAFU(ip)-OH (8) starts from d-Glc, turned subsequently into the azido derivative (7). Reagents and conditions: a (CH 3 ) 2 CO, H 2 SO 4 ; b NaH, Im 2 SO 2 , DMF; c NaN 3 , Bu 4 NBr, toluene; d 75% AcOH; e 1. NaIO 4 , ). This expected product (9) might be also highly unstable, as solely the related O-protected derivatives were described in the literature (Nagy et al. 2017; Csordás et al. 2016; Gruner et al. 2002a, b; Masamune et al. 2001; Dauban et al. 1996) . Both the starting 7 and the product 9 could be detected with their exact masses, however, the retention time of 7 was short and the peak shape of 9 was not sufficient sharp. Indeed, the separation has to be further optimized to obtain better quality chromatographic peaks, thus, the integration and comparison can be made for following the reactions. Analogue reaction of N 3 -RibAFU(ip)-NHMe (11) in TFA/DCM (50%) with TIS (2.5%) and H 2 O (2.5%) was stirred at room temperature for 1 h to be completed according to TLC and RP-HPLC (SFig. 26). The signal of the expected product 12 appeared at about 2 min and indicated the mixture of products also in this case. Working up the reaction mixture gave a solid which could not be separated to give pure anomers. Formation of more products was attributed to the free OH-1 in 12-as in the case of 9. Additional reasons for the dispersity of the peak at 2 min was revealed by ESI-MS exhibiting the isotopic peak of an isobaric contaminant at m/z 203.822 beside of the peak of the mixture of 12 at m/z 203.07803 (SFig. 10). In Route B: Compound 7 was dissolved in the solution of TFA/dried MeOH in parallel concentrations of 30%, 50% and 70%. The mixtures were kept for 18 h at room temperature then were processed to give oily products from each sample. Analysis with RP-HPLC revealed complex mixtures in all cases (SFig. 27). Only the decreasing signal of the starting 7 was unambiguously assigned between 11.7 and 12 min, respectively, depending on the TFA concentration. Further components-intermediates and side productswere detected in all cases. The formation of the intermediate 14 in the reaction mixture of concentration of 30% TFA was identified (SFig. 5). Attempted separation of the components failed from the oily mixtures, thus, Route B was not continued. In Route C: These reactions of the starting 7 were carried out under heterogeneous conditions: Amberlite IR-120 H + resin was used as the acid component in dried MeOH. The mol ratio was in parallel reactions: 2, 4, 8 and 12 eqv. The mixtures were kept at 60 °C, 40 °C and at room temperature till to the reaction was complete. Analysis of RP-HPLC chromatograms revealed that 1,2-O-isopropylidene deprotection on 7 (11.9 min) occurred, parallel, with the formation of the methyl ester methyl furanoside (10) as final main product (9.0 min). Besides, two further peaks were detected at 6.8 min and at 15.3 min, respectively. These were reasonably assigned to the temporary intermediate methyl esters (14 and 15) . The best results were obtained from the reaction with 8 eqv. Amberlite IR-120 H + at 60 °C when almost complete transformation occurred in 360 min (Fig. 2) . Parallel reactions at 40 °C and at room temperature terminated after 1 day and 4 days, respectively. The conversion to product 10 was near to 90% in each case (Table 2 , STable 1, STable 2). Quantitative analysis of the RP-HPLC diagram of the best experiment revealed the disappearance of the starting 7 after 60 min, and that of the intermediate 14 after 240 min (Fig. 3) . The mixture of products contained mainly the final product 10 (89%) and also intermediate 15 (~ 10%; not isolated) ( Table 2) . Working up the mixture gave inseparable oil. The 1 H NMR and ESI-MS were measured with the best mixture. The 1 H NMR signals of the 1,2-O-isopropylidene group of the starting 7 (at δ 1.28 and 1.44 ppm) disappeared in the spectrum of the methyl glycoside product (10). At the same time, the spectrum of the latter exhibited the characteristic methyl signals of the methyl ester and the methyl O-glycoside at 3.84 and 3.42 ppm, respectively ( Fig. 4 and SFig. 4) . The ratio of the anomers calculated from the H-1 signals shows that α-anomer ( 3 J coupling of H1-H2: < 1.0 Hz) is the main component and the β-anomer ( 3 J couplings of H1-H2: 11.5 Hz) is the minor one. ESI-MS exhibited m/z [M+Na] + 240.1 for C 7 H 11 N 3 O 5 supporting the molecular composition of 10. The small quantity of the minor component did not (Fig. 2, Fig. 3 , Table 2 , SFig. 20, SFig. 21, SFig. 25, STable 1, STable 2) allow the detailed analysis, however, the evident presence of 15 in the reaction mixture was supported by the mechanism of the complex reaction (Scheme 1). Analogue reaction of N 3 -RibAFU(ip)-NHMe (11) was carried out under the best conditions as in the case of 7: with Amberlite IR-120 H + (8 eqv.)/dried MeOH at 60 °C and completed within 300 min. Analysis of RP-HPLC diagrams revealed that 1,2-O-isopropylidene deprotection on 11 (9.9 min) occurred, parallel, with the formation of the expected methyl furanoside (13) as final main product (at 4.5 min, SFig. 25). Besides, a second product was observed at 3 min, probably, the 1,2-(OH) 2 derivative (12). Working up the reaction mixture gave an inseparable oily Our ultimate goal was to apply the currently fine-tuned deprotection method for making various peptides and chimera sequences. The previously successfully applied Fig. 2 The 1,2-O-isopropylidene removal from N 3 -RibAFU(ip)-OH as function of the time resolved by RP-HPLC: compound 7 treated with 8 eqv. of Amberlite IR-120 H + resin in MeOH at 60 °C. Decreasing concentration of the starting 7 and the increasing one of the main product (10) were assigned with 1 H-NMR and MS data -GG-X-GG-model system was synthesized here with X=RibAFU(ip) and conditions to remove its 1,2-O-isopropylidene protecting group were probed. The synthesis of -GG-RibAFU(ip)-GG-was carried out with Fmoc-strategy introducing Fmoc-RibAFU(ip)-OH (8) on RAM-Tentagel ® or 2-Cl-Trt-Cl resin (Scheme 3) by PyBOP/DIEA which was found as one of the most effective coupling reagents for SAAs (Nagy et al. 2019; Goldschmidt Gőz et al. 2019) . The N-terminus of this model peptide were protected to avoid unwanted side-reactions (e.g. esterification). Peptide 18 was used for evaluation of peptide synthesis method and an intermediate of methyl glycoside formation. The deprotection of 1,2-O-isopropylidene moiety was carried out with the mixture of TFA/DCM/TIS/H 2 O which is in fact a common cleavage cocktail in SPPS. The 50% TFA condition was used to remove peptides from the resin and in parallel to complete the 1,2-O-isopropylidene deprotection (Scheme 3, step e). The removal of the 1,2-O-isopropylidene group gave successfully both pentapeptides with free 1,2-OHs (16, 17) . In the mixture of the crude product, 4:1/α:β anomeric ratio was observed at 11.29 min and 12.04 min, respectively (Fig. 5) . The formation of methyl glycoside was accomplished after the final cleavage (Scheme 3, step g and h) using two routes. The Amberlite (19) pentapeptide was observed. However, Route E was faster for methyl glycoside formation, with retention times of 4.75 min and 5.54 min presenting a 4:1/α:β anomeric ratio, respectively (SFig. 19). Although RP-HPLC was used to follow the deprotection reaction, there were components (9, 12, 13) and peptides (16, 17, 19) having a short retention time due to their increased hydrophilicity. The analysis of these polar compounds was a challenge, as their interaction with C-18 stationary phases was insufficient, leading to a very difficult product isolation. Products (9, 16, 17, 19) were characterized via HILIC LC-UV-MS (Jablonski, Hudalla and Fountain 2012; Yoshida 2004 ) measurements with BEH Amide column capable of analyzing hydrophilic SAAs or sequences (Fig. 5) . The optimized condition was found to enhance the retention of hydrophilic polypeptides, making analysis and isolation more adequate. A rather general 1,2-O-isopropylidene deprotection method was worked out for α/β-chimera peptides using a suitable d-ribo furanoid β-SAA model system, namely the N 3 -RibAFU(ip)-OH synthetic intermediate. To obtain the unprotected derivatives, two different conditions were studied successfully, namely (1) various TFA concentrations to form the free 1,2-OH product (9) and (2) various equivalents of Amberlite IR-120 H + resin or TFA in MeOH forming methyl glycoside (10) to prevent the furanoid ring opening. In the first case, 50% TFA in DCM with TIS and H 2 O as scavengers was found to give the fully unprotected compound (N 3 -RibAFU-OH, 9). Furthermore, 8 eqv. Amberlite IR-120 H + resin in MeOH at 60 °C turned out to be optimum to furnish methyl glycoside methyl ester N 3 -RibAFU(Me)-OMe (10). These optimized methods, 50% TFA and H + resin/MeOH, were applied successfully during the synthesis of α/β-chimera oligopeptide [-GG-RibAFU(ip)-GG-] to form the Ac-GG-RibAFU-GG-NH 2 (16) without 1,2-O-isopropylidene protection and the methyl glycoside variant, namely the Ac-GG-RibAFU(Me)-GG-OMe (19). The described, fine-tuned conditions of deprotection were shown to be appropriate and sufficiently mild to remove 1,2-O-isopropylidene protection in oligo-and polypeptides of more complex amino acid sequences. Reagents, materials and solvents were obtained from Sigma-Aldrich, Merck, Reanal and VWR. Moisture-sensitive solvents were dried on molecular sieve (3 Å). The capacity of Amberlite IR-120 H + resin was 1.80 eq/L. Compound 7 was prepared based on previous results of our group (Nagy et al. 2017 Compound 8 was prepared based on previous results of our group (Nagy et al. 2017 1,2-O-isopropylidene-3-azido-3-deoxy-α-d-ribofuranuronic acid (7, 200 mg; 0.87 mmol) was dissolved in DCM (49 ml), then CH 3 NH 2 ·HCl (120 mg), EDC·HCl (671 mg), DIEA (0.6 ml) and HOBt (235 mg) were added. The mixture was stirred at room temperature for 3 h (EtOAc- The removal of 1,2-O-isopropylidene protection from the azido derivative (7) 3-Azido-3-deoxy-d-ribofuranuronic acid (9) (A) 1 , 2 -O -I s o p r o p y l i d e n e -3 -a z i d o -3 -d e o x y -αdribofuranuronic acid (7, 100 mg; 0.44 mmol) was dissolved in 5 ml of different concentrations of TFA (50%, 70%) in DCM (45% and 25%, respectively) with TIS (2.5%) and H 2 O (2.5%). The mixtures were stirred at room temperature for 3 h and evaporated in vacuo. The residues were dissolved in 1,2-dimethoxyethane (5 ml) and concentrated to obtain white oils in both cases. (B) 1,2-O-Isopropylidene-3-azido-3-deoxy-α-dribofuranuronic acid (7, 50 mg; 0.22 mmol) was added into 2.5 ml mixtures of TFA (50%, 70%, 90%) in DCM (45%, 25%, 5%, respectively), TIS (2.5%) and H 2 O (2.5%). Reactions were stirred at room temperature. Fractions of reaction mixtures were concentrated by air blowing, diluted in water then measured by RP-HPLC (SFig. 22, SFig. 23, SFig. 24). 1,2-O-Isopropylidene-3-azido-3-deoxy-α-dribofuranuronic acid (7, 50 mg; 0.22 mmol) was dissolved in dried MeOH (2 ml) and Amberlite IR-120 H + resin (2, 4, 8 and 12 eqv. corresponding to 100, 200, 400 or 600 mg) were added. The mixtures were heated to 60 °C for 6 h. The reactions were followed by RP-HPLC (SFig. 20, SFig. 21). The mixtures were filtered and washed with MeOH. Filtrates were evaporated in vacuo to obtain oil products. The mixture of products containing mainly the final product 10 (~ 90%) was characterized. RP-HPLC: 9.0 min; ESI-MS: m/z calculated for C 7 H 11 N 3 O 5 [M+Na] + 240.1, found 240.1; 1 H NMR (CDCl 3 , 250 MHz) δ ppm 4.93 (s, 1H), 4.58 (d, J = 7.2 Hz, 1H), 4.36 (m, 1H), 4.16 (d, J = 4.4 Hz, 1H), 3.83 (s, 3H), 3.42 (s, 3H). (B) 1,2-O-Isopropylidene-3-azido-3-deoxy-α-dribofuranuronic acid (7, 50 mg; 0.22 mmol) was dissolved in dried MeOH (2 ml) and Amberlite IR-120 H + resin (400 mg, 8 eqv.) was added to the solution. The reaction mixture was stirred at different temperatures (60 °C, 40 °C and RT). Fractions of reaction mixtures were neutralized (NaHCO 3 ), centrifuged, diluted in MeOH then measured by RP-HPLC (STable 1, STable 2). (C) 1,2-O-Isopropylidene-3-azido-3-deoxy-α-dribofuranuronic acid (7, 50 mg; 0.22 mmol) was added into 2 ml mixtures of TFA (30%, 50%, 70%) and dried MeOH (70%, 50%, 30%, respectively). Reactions were stirred at room temperature overnight and evaporated in vacuo to obtain oil product. Mixtures were measured by RP-HPLC (SFig. 27). Grant (VEKOP-2.3.2-16-2017-00014) and the purchase of the mass spectrometer was supported by Grant (VEKOP-2.3.3-15-2017-00020) from the European Union and the State of Hungary, co-financed by the European Regional Development Fund. Funding Open access funding provided by Eötvös Loránd University. Conflict of interest The authors declare that they have no conflict of interest. Research involving human participants and/or animals This article does not contain any studies with human participants or animals performed by any of the authors. Informed consent Informed consent was obtained from all individual participants included in this study. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/. A systematic study of the solid state and solution phase conformational preferences of β-peptides derived from transpentacin Selective deprotection of terminal isopropylidene acetals and trityl ethers using HClO 4 supported on silica gel Towards functional fluorous surfactants. Synthesis and spectroscopic features of systematically modified sugar-substituted fluorous 1,2,3-triazoles Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase ) β-peptide foldamers: robust helix formation in a new family of β-amino acid oligomers Synthesis and characterization of trans-2-aminocyclohexanecarboxylic acid oligomers: an unnatural helical secondary structure and implications for β-peptide tertiary structure Synthesis and structural characterization of helix-forming β-peptides: trans-2-aminocyclopentanecarboxylic acid oligomers Synthesis of cyclic oligomers of a modified sugar amino acid utilising dynamic combinatorial chemistry Sugar amino acids and their uses in designing bioactive molecules Formation of a stable 14-helix in short oligomers of furanoid cis-β-sugar-amino acid Chemoselective deprotection of acid labile primary hydroxyl protecting groups under CBr 4 -photoirradiation conditions Origin of problems related to staudinger reduction in carbopeptoid syntheses Synthesis of optically pure 3,4-disubstituted l-glutamates from a novel 2,3-aziridino-γlactone 4-carboxylate derivative Asymmetric total synthesis of C9′-epi-Sinefungin Heterocycles from carbohydrate isothiocyanates Highly efficient singlet oxygen generators based in ruthenium phthalocyanines: synthesis, characterization and in vitro evaluation for photodynamic therapy Enantiospecific syntheses of deoxymannojirimycin, fagomine and 2R,5R-dihydroxymethyl-3R,4R-dihydroxypyrrolidine from d-glucose Nicotinyl riboside compounds and their uses Spiranic d-gluco-configured N-substituted thiohydantoins as potential enzymatic inhibitors From substrate to fragments to inhibitor active in vivo against Staphylococcus aureus Foldamers: a manifesto Approaches to pyranuronic β-sugar amino acid building blocks of peptidosaccharide foldamers Unwanted hydrolysis or α/β-peptide bond formation: how long should the rate-limiting coupling step take? Carbohydratebased mimetics in drug design: sugar amino acids and carbohydrate scaffolds Design, synthesis, and NMR structure of linear and cyclic oligomers containing novel furanoid sugar amino acids Chainlength-dependent helical motifs and self-association of β-peptides with constrained side chains Stabilisation of peptide foldamers in an aqueous medium by incorporation of azapeptide building blocks A field guide to foldamers A simple regioselective partial hydrolysis of di-O-isorpopylidene monosaccharides with copper(II) ion Preparative scale chromatography of a hydrophilic peptide using hydrophilic interaction chromatography. Water Application Note Part number Efficient and selective cleavage of acetals and ketals using ferric chloride adsorbed on silica gel Antibodydrug conjugate (ADC) and method for forming the same Highly selective β-mannosylations and β-rhamnosylations catalyzed by a bis-thiourea Novel position-specific 18 O/ 16 O measurement of carbohydrates. II. The complete intramolecular 18 O/ 16 O profile of the glucose unit in a starch of C4 origin Metal-free deprotection of terminal acetonides by using tert-butyl hydroperoxide in aqueous medium cis-2-aminocyclopentanecarboxylic acid oligomers adopt a sheetlike structure: switch from helix to nonpolar strand Compounds for the treatment of ischemia Cyclic acetals and ketals. In: Carbohydrates: synthesis, mechanisms and stereoelectronic effects C-3 epimers of sugar amino acids as foldameric building blocks: improved synthesis, useful derivatives, coupling strategies 2019) α/β-chimera peptide synthesis with cyclic β-sugar amino acids: the efficient coupling protocol A mild and convenient approach for selective acetonide cleavage involved in carbohydrate synthesis using PPA-SiO 2 Synthesis and structural characterization of homochiral homo-oligomers of parent cis-and transfuranoid-β-amino acids Polymers from sugars and unsaturated fatty acids: ADMET polymerisation of monomers derived from d-xylose, d-mannose and castor oil Preparation of heparin fragments and immobilized biological entities Triazoxins: novel nucleosides with anti-Giardia activity Zeolites and other silicon-based promoters in carbohydrate chemistry Novel process for making allofuranose from glucofuranose Selective synthesis of new sugars based on 8-hydroxyquinoline as corrosion inhibitors for mild steel in HCl solution-effect of the saturated hydrocarbon chain: theoretical and experimental studies Pyranocyclopropanyl sugar amino acids, a new class of constrained (di)peptide isosteres A compendium of cyclic sugar amino acids and their carbocyclic and heterocyclic nitrogen analogues Synthesis of an analog of the nucleoside moiety of the polyoxins ) β-peptides: synthesis by Arndt-Eistert homologation with concomitant peptide coupling. Structure determination by NMR and CD spectroscopy and by X-ray crystallography. Helical secondary structure of a β-hexapeptide in solution and its stability towards pepsin Stereoselective phenylselenoglycosylation of glycals bearing a fused carbonate moiety toward the synthesis of 2-deoxy-β-galactosides and β-mannosides Synthesis of a bicyclic analogue of AZT restricted in an unusual O4′-endo conformation Efficient synthesis of carbopeptoid oligomers: insight into mimicry of β-peptide 19(R)-, and 12(S),19(S)-dihydroxyeicosacis-5,8,14-trans-10-tetraenoic acids Total synthesis of tricolorin A via interrupted pummerer reaction mediated glycosylation and one-pot relay glycosylation A mild and efficient method for chemoselective deprotection of acetonides by bismuth(III) trichloride Chemical synthesis and immunological evaluation of Helicobacter pylori Serotype O6 tridecasaccharide O-antigen containing a unique dd-heptoglycan An efficient, selective hydrolysis of terminal isopropylidene acetal protection by Zn(NO 3 ) 2 ·6H 2 O in acetonitrile Synthesis of glycomimetics by diastereoselective passerini reaction 3-dideoxy-3-nitro-d-eryt-phreontofuranoside, isomers and derivatives Onepot relay glycosylation 11(R), 12(R)-trihydroxyeicosa-5(Z), 8(Z), 14(Z)-trienoic acid from d-mannose Yb(OTf) 3 ·H 2 O: a novel reagent for the chemoselective hydrolysis of isopropylidene acetals Synthesis and biological evaluation of a MraY selective analogue of tunicamycins. Nucleosides Nucleotides Nucleic Acids Synthesis of cyclic α-amino Acids. IV. Syntheses of adenine nucleosides of 3-amino-3-C-carboxy-3-deoxy-d-ribopyranose GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation Peptide separation by hydrophilic-interaction chromatography: a review Synthesis of 1,2,5-tri-O-benzoyl-3-dibenzylamino-3-deoxyribose as intermediate for producing 3′-amino-3′-deoxyadenosine and 3′-amino-3′-deoxyguanosine and the protected derivatives thereof The authors gratefully acknowledge Gitta Schlosser for her help in HILIC LC-UV-MS measurements and analysis. We also wish to thank Viktor Farkas for RP-HPLC support and István Varga for NMR measurements. This work was supported by The removal of 1,2-O-isopropylidene protection from methylamide derivative (11) Compound 11 (40 mg; 0.17 mmol) was dissolved in the mixture (2 ml) of TFA (50%), DCM (45%), TIS (2.5%) and H 2 O (2.5%) and stirred at room temperature for 1 h. The reaction was monitored by TLC (EtOAc-Hex 2:1) and Model peptide SPPS of the model peptide was executed manually on RAM-Tentagel ® or 2-Cl-Trt-Cl resin with the standard methodology using Fmoc-strategy. Resins were swollen in DCM. Coupling of Fmoc-Gly-Gly-OH to resins was implemented in two different methods. For RAM-Tentagel ® resin, the first step was the removal of Fmoc-group conducted with 2% piperidine and 2% DBU in DMF (10 + 20 min). The coupling was accomplished using Fmoc-Gly-Gly-OH (3 eqv. to the nominal capacity of the resin ~ 0.24 mmol/g) dissolved in DMF and PyBOP (3 eqv.)/ DIEA (6 eqv.) added to the solution. In the case of 2-Cl-Trt-Cl resin, the coupling was made with Fmoc-Gly-Gly-OH (1.5 eqv. to the nominal capacity of the resin ~ 1.60 mmol/g to tune down to 0.28 mmol/g) which was dissolved in DMF and DIEA (3.75 eqv.) was added to the solution. Afterwards, amino acids were coupled to resins using reagent pairs PyBOP/DIEA in DMF. Coupling of amino acids lasted for 1 h, whereas that of Fmoc-RibAFU(ip)-OH finished in 3 h. After coupling, resins were washed with 3 × DMF, 3 × DCM, 2 × MeOH, 1 × Et 2 O and dried in vacuo. The capacity of the resin was determined by spectrometric measurement of the amount of Fmoc chromophore (Fmoc-piperidine adduct) released upon treatment of the resin with 50% piperidine in DMF (Chan and White 2000) . Fmoc-deprotection was done by 2% piperidine and 2% DBU in DMF (3 + 17 min). The successful removal was analyzed by Kaiser test. The acetylation was performed with Ac 2 O:DIEA:DMF (1:1.2:3) for 30 min.Ac-Gly-Gly-RibAFU-Gly-Gly-NH 2 (16) The peptide was cleaved from RAM-Tentagel ® resin (50 mg) with TFA (50%), DCM (45%), TIS (2.5%) and H 2 O (2.5%) for 3 h. The resin was washed with 3 × DCM and 3 × MeOH, then solvent was removed in vacuo. The residue was treated with cold Et 2 O to precipitate white solid product (4.9 mg). HILIC LC-UV-MS: 11.29 min and 12.04 min, m/z calculated for C 15 Ac-Gly-Gly-RibAFU-Gly-Gly-OH (17) The peptide was cleaved from 2-Cl-Trt-Cl resin (150 mg) by a mixture of TFA (50%), DCM (45%), TIS (2.5%) and H 2 O (2.5%) for 3 h. The resin was washed with 3 × DCM and 3 × MeOH, then solvent was removed in vacuo. By treating the residue with cold Et 2 O, the white solid product was precipitated (14.1 mg) The peptide was cleaved from 2-Cl-Trt-Cl resin (150 mg) with AcOH:MeOH:DCM (1:1:8) for 3 h. The resin was washed with 3 × DCM, 3 × iPrOH and 1 × Et 2 O. The solvent was removed in vacuo. The residue was precipitated in cold Et 2 O to obtain white solid product (11.4 mg, 58% (B) Peptide 18 (10 mg) was dissolved in dried MeOH with Amberlite IR-120 H + (8 eqv.). The mixture was stirred at 60 °C for 6 h, filtered and washed with MeOH. The filtrate was concentrated in vacuo and the residue was treated in cold Et 2 O to obtain white solid product (6.7 mg). The online version of this article (https ://doi.org/10.1007/s0072 6-020-02923 -3) contains supplementary material, which is available to authorized users.